Bright Health reports Q2 EPS ($15.70), consensus ($5.44)

Reports Q2 revenue $297.98M, consensus $752.05M. “Bright Health showed continued strong performance in the Q2including reporting our Q1 with positive Adjusted EBITDA. Our Care Delivery and Care Solutions operating segments both performed well, with each generating positive Operating Income in the quarter,” said Mike Mikan, President and CEO of Bright Health. “Additionally, we expect the sale of our California Medicare Advantage announced at the end of the Second Quarter will bolster our Balance Sheet to continue on our path to long-term profitable growth.”